CRISPR Therapeutics AG (CRSP)

CRISPR Therapeutics AG Azioni (CRSP) Dati Finanziari

Conto economico

Trimestrale

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	99.75% 0.504	201.21	-	70.00	100.00
Operating Expenses	7.19% 141.09	131.62	132.41	165.22	164.49
Benefits Costs and Expenses	4.25% 116.37	111.63	111.74	146.82	151.75
Costs And Expenses	4.25% 116.37	111.63	111.74	146.82	151.75
Operating Income/Loss	302.04% -140.59	69.58	-132.41	-95.22	-64.49
Nonoperating Income/Loss	23.62% 24.72	20.00	20.67	18.41	12.74
Income/Loss From Continuing Operations Before Tax	229.34% -115.87	89.58	-111.74	-76.82	-51.74
Income Tax Expense/Benefit	210.73% 0.724	0.233	0.412	0.923	1.32
Income/Loss From Continuing Operations After Tax	230.49% -116.59	89.35	-112.15	-77.74	-53.06
Net Income/Loss	230.49% -116.59	89.35	-112.15	-77.74	-53.06
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	51,828% 81.79	0.1575	79.41	79.09	78.68
Diluted Average Shares	51,828% 81.79	0.1575	79.41	79.09	78.68
Basic Earnings Per Share	226.55% -1.43	1.13	-1.41	-0.98	-0.67
Diluted Earnings Per Share	226.55% -1.43	1.13	-1.41	-0.98	-0.67
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-